# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 1wn3:A (2.1) | BS01 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
2 | 1wn3:B (2.1) | BS01 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
3 | 1wn3:C (2.1) | BS01 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
4 | 1wn3:C (2.1) | BS02 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
5 | 1wn3:D (2.1) | BS01 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
6 | 1wn3:D (2.1) | BS02 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
7 | 1wn3:E (2.1) | BS01 | ACT | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
8 | 1wn3:E (2.1) | BS02 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
9 | 1wn3:F (2.1) | BS01 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
10 | 1wn3:G (2.1) | BS01 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
11 | 1wn3:G (2.1) | BS02 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
12 | 1wn3:H (2.1) | BS01 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 | |
13 | 1wn3:H (2.1) | BS02 | HXC | ? | GO:0016289 ... | Q5SJP3 | 16061252 |